RESUMEN
p21-activated kinases (PAKs) are protein serine/threonine kinases stimulated by Rho-family p21 GTPases such as CDC42 and RAC. PAKs have been implicated in several human disorders, with pathogenic variants in PAK3 associated with intellectual disability and several PAK members, especially PAK1 and PAK4, overexpressed in human cancer. Recently, de novo PAK1 variants were reported to be causative of neurodevelopmental disorder (ND) with secondary macrocephaly in three patients. We herein report a fourth patient with ND, epilepsy, and macrocephaly caused by a de novo PAK1 missense variant. Two previously reported missense PAK1 variants functioned as activating alleles by reducing PAK1 homodimerization. To examine the pathogenicity of the identified novel p.Ser110Thr variant, we carried out in silico structural analysis. Our findings suggest that this variant also prevents PAK1 homodimerization, leading to constitutive PAK1 activation.
Asunto(s)
Epilepsia , Megalencefalia , Mutación Missense , Trastornos del Neurodesarrollo , Multimerización de Proteína , Quinasas p21 Activadas , Sustitución de Aminoácidos , Niño , Activación Enzimática/genética , Epilepsia/enzimología , Epilepsia/genética , Humanos , Masculino , Megalencefalia/enzimología , Megalencefalia/genética , Trastornos del Neurodesarrollo/enzimología , Trastornos del Neurodesarrollo/genética , Dominios Proteicos , Quinasas p21 Activadas/química , Quinasas p21 Activadas/genética , Quinasas p21 Activadas/metabolismoRESUMEN
The human 1q21.1 deletion of ten genes is associated with increased risk of schizophrenia. This deletion involves the ß-subunit of the AMP-activated protein kinase (AMPK) complex, a key energy sensor in the cell. Although neurons have a high demand for energy and low capacity to store nutrients, the role of AMPK in neuronal physiology is poorly defined. Here we show that AMPK is important in the nervous system for maintaining neuronal integrity and for stress survival and longevity in Drosophila. To understand the impact of this signaling system on behavior and its potential contribution to the 1q21.1 deletion syndrome, we focused on sleep, an important role of which is proposed to be the reestablishment of neuronal energy levels that are diminished during energy-demanding wakefulness. Sleep disturbances are one of the most common problems affecting individuals with psychiatric disorders. We show that AMPK is required for maintenance of proper sleep architecture and for sleep recovery following sleep deprivation. Neuronal AMPKß loss specifically leads to sleep fragmentation and causes dysregulation of genes believed to play a role in sleep homeostasis. Our data also suggest that AMPKß loss may contribute to the increased risk of developing mental disorders and sleep disturbances associated with the human 1q21.1 deletion.
Asunto(s)
Proteínas Quinasas Activadas por AMP/genética , Anomalías Múltiples/enzimología , Anomalías Múltiples/genética , Megalencefalia/enzimología , Megalencefalia/genética , Neuronas/enzimología , Esquizofrenia/enzimología , Esquizofrenia/genética , Sueño/genética , Sueño/fisiología , Proteínas Quinasas Activadas por AMP/antagonistas & inhibidores , Proteínas Quinasas Activadas por AMP/deficiencia , Animales , Deleción Cromosómica , Cromosomas Humanos Par 1/enzimología , Cromosomas Humanos Par 1/genética , Proteínas de Drosophila/deficiencia , Proteínas de Drosophila/genética , Drosophila melanogaster/enzimología , Drosophila melanogaster/genética , Femenino , Técnicas de Silenciamiento del Gen , Predisposición Genética a la Enfermedad , Humanos , Aprendizaje/fisiología , Longevidad/genética , Longevidad/fisiología , Masculino , Modelos Animales , Neuronas/citología , Factores de Riesgo , Transducción de Señal , Trastornos del Sueño-Vigilia/enzimología , Trastornos del Sueño-Vigilia/genéticaRESUMEN
The megalencephaly capillary malformation syndrome (MCAP, OMIM 602501) is known to be associated with mosaic mutations in PIK3CA occurring during embryogenesis. Standard sequencing technologies are relatively poor at indentifying sequence changes that only affect a small percentage of cells, and the mutations are frequently not identified in lymphocyte DNA, with biopsies of the affected tissues often being required to detect mosaic mutations. Such invasive procedures are not always acceptable to parents. We describe the case of a patient in whom we were able to confirm a causative PIK3CA mutation, first found thorugh next-generation sequencing, in several tissue types including a secondary tooth. As part of this work, we were also able to begin validating dental tissue for potential use in genetic testing, as we achieved excellent DNA yields with minimal effort, even from deciduous teeth shed some years earlier.
Asunto(s)
Anomalías Múltiples/genética , Megalencefalia/genética , Fosfatidilinositol 3-Quinasas/genética , Enfermedades Cutáneas Vasculares/genética , Telangiectasia/congénito , Anomalías Múltiples/enzimología , Adolescente , Fosfatidilinositol 3-Quinasa Clase I , ADN/análisis , ADN/genética , Análisis Mutacional de ADN , Pulpa Dental/química , Femenino , Humanos , Megalencefalia/enzimología , Mutación , Enfermedades Cutáneas Vasculares/enzimología , Telangiectasia/enzimología , Telangiectasia/genéticaRESUMEN
Megalencephaly-capillary malformation (MCAP) and megalencephaly-polymicrogyria-polydactyly-hydrocephalus (MPPH) syndromes are sporadic overgrowth disorders associated with markedly enlarged brain size and other recognizable features. We performed exome sequencing in 3 families with MCAP or MPPH, and our initial observations were confirmed in exomes from 7 individuals with MCAP and 174 control individuals, as well as in 40 additional subjects with megalencephaly, using a combination of Sanger sequencing, restriction enzyme assays and targeted deep sequencing. We identified de novo germline or postzygotic mutations in three core components of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway. These include 2 mutations in AKT3, 1 recurrent mutation in PIK3R2 in 11 unrelated families with MPPH and 15 mostly postzygotic mutations in PIK3CA in 23 individuals with MCAP and 1 with MPPH. Our data highlight the central role of PI3K-AKT signaling in vascular, limb and brain development and emphasize the power of massively parallel sequencing in a challenging context of phenotypic and genetic heterogeneity combined with postzygotic mosaicism.
